Atreca, Inc.
BCEL
P
|
$0.0775
0.0%
52K
|
Health Technology
(0.0% 1d) (22.6% 1m) (-92.0% 1y) (0.0% 2d) (0.0% 3d) (-6.2% 7d) (-37.79% volume)
Earnings Calendar: 2024-04-16
Market Cap: $ 2,550,419
http://www.atreca.com
Sec Filling | Patents | 113 employees
(US) Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in South San Francisco, CA.
antibody immunotherapy
add to watch list Paper trade email alert is off
Press-releases
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
Published: 2023-12-26 (Crawled : 13:30) - globenewswire.com
IMNM | $17.175 -1.18% -1.19% 850K
|
Health Technology
|
| O: 1.81%
H: 6.9%
C: 6.28%
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: 6.77%
H: 6.34%
C: -27.62%
agreement
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives
Published: 2023-11-14 (Crawled : 22:00) - globenewswire.com
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: -7.8%
H: 8.42%
C: -16.5%
financial results
Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer
Published: 2023-10-04 (Crawled : 13:00) - biospace.com/
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: 4.35%
H: 7.08%
C: 6.0%
medical therapeutics
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
Published: 2023-09-21 (Crawled : 12:30) - globenewswire.com
ARE A | $116.51 0.05% -0.01% 1.1M
|
Finance
|
| O: -0.93%
H: 0.45%
C: -7.44%
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: -0.03%
H: 12.12%
C: -1.21%
financial agreement
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
Published: 2023-09-18 (Crawled : 20:00) - ir.anaptysbio.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: -5.7%
H: 7.24%
C: 5.75%
ANAB | $19.84 -7.59% -8.32% 360K
|
Health Technology
|
| O: -0.52%
H: 0.42%
C: -3.29%
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: -3.34%
H: 0.0%
C: -34.38%
financial results
Esophageal Cancer Market to Proliferate at a CAGR of 5.9% During the Study Period (2019-2032), Estimates DelveInsight
Published: 2023-07-06 (Crawled : 21:00) - prnewswire.com
ATNXQ | $0.0152 -85.53% 3.6K
|
Manufacturing
|
| O: 54.31%
H: 0.0%
C: -29.37%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.19%
H: 0.28%
C: -2.22%
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: 0.17%
H: 0.72%
C: -0.97%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
LPTX | $2.96 -1.33% -1.35% 100K
|
Health Technology
|
| O: -0.79%
H: 6.03%
C: -0.63%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -0.14%
H: 0.16%
C: -1.12%
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: 0.05%
H: 0.64%
C: -0.47%
CRIS | $14.96 -6.21% -6.62% 20K
|
Health Technology
|
| O: 1.29%
H: 5.24%
C: -5.26%
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: -1.1%
H: 7.53%
C: 5.06%
cancer study market
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
Published: 2023-06-05 (Crawled : 12:00) - globenewswire.com
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: 5.2%
H: 0.0%
C: -1.9%
atrc-101 asco tumors ongoing meeting study
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
Published: 2023-05-10 (Crawled : 20:00) - globenewswire.com
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: -1.79%
H: 2.73%
C: -13.32%
financial results
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
Published: 2023-05-08 (Crawled : 23:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
RVMD S | $35.81 -2.74% -2.82% 1M
|
Health Technology
|
| O: 0.12%
H: 0.37%
C: 0.29%
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: 3.0%
H: 1.94%
C: 1.94%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.5%
H: 0.17%
C: -0.31%
update financial results
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10